Annual Statements Open main menu

AMETEK INC/ - Quarter Report: 2015 September (Form 10-Q)

Form 10-Q
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2015

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For the transition period from              to             

Commission File Number 1-12981

AMETEK, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   14-1682544

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

1100 Cassatt Road

Berwyn, Pennsylvania

  19312-1177
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (610) 647-2121

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer þ   Accelerated filer ¨   

Non-accelerated filer ¨

(Do not check if a smaller reporting company)

  Smaller reporting company ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No þ

The number of shares of the registrant’s common stock outstanding as of the latest practicable date was: Common Stock, $0.01 Par Value, outstanding at October 28, 2015 was 237,882,582 shares.

 

 

 


Table of Contents

AMETEK, Inc.

Form 10-Q

Table of Contents

 

     Page  

PART I. FINANCIAL INFORMATION

  

Item 1. Financial Statements

  

Consolidated Statement of Income for the three and nine months ended September 30, 2015 and 2014

     2   

Consolidated Statement of Comprehensive Income for the three and nine months ended September  30, 2015 and 2014

     3   

Consolidated Balance Sheet at September 30, 2015 and December 31, 2014

     4   

Condensed Consolidated Statement of Cash Flows for the nine months ended September 30, 2015 and 2014

     5   

Notes to Consolidated Financial Statements

     6   

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     17   

Item 4.Controls and Procedures

     24   

PART II. OTHER INFORMATION

  

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

     25   

Item 6. Exhibits

     26   

SIGNATURES

     27   

 

1


Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

AMETEK, Inc.

Consolidated Statement of Income

(In thousands, except per share amounts)

(Unaudited)

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2015     2014     2015     2014  

Net sales

   $ 998,527      $ 1,031,811      $ 2,986,312     $ 2,997,821   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating expenses:

        

Cost of sales, excluding depreciation

     631,790        677,739        1,901,680        1,933,554   

Selling, general and administrative

     112,116        119,205        335,702        345,146   

Depreciation

     17,006        16,724        50,044        47,619   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     760,912        813,668        2,287,426        2,326,319   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     237,615        218,143        698,886        671,502   

Other expenses:

    

Interest expense

     (23,684     (19,543     (69,048     (57,362

Other, net

     (2,325     (8,639     (6,298     (16,842
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes

     211,606        189,961        623,540        597,298   

Provision for income taxes

     55,208        48,150        169,522        164,838   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 156,398     $ 141,811     $ 454,018     $ 432,460  
  

 

 

   

 

 

   

 

 

   

 

 

 

Basic earnings per share

   $ 0.65     $ 0.58     $ 1.89     $ 1.76  
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted earnings per share

   $ 0.65     $ 0.57     $ 1.87     $ 1.75  
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average common shares outstanding:

    

Basic shares

     239,959       245,439       240,801       245,184  
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted shares

     241,238       247,643       242,552       247,425  
  

 

 

   

 

 

   

 

 

   

 

 

 

Dividends declared and paid per share

   $ 0.09     $ 0.09     $ 0.27     $ 0.24  
  

 

 

   

 

 

   

 

 

   

 

 

 

See accompanying notes.

 

2


Table of Contents

AMETEK, Inc.

Consolidated Statement of Comprehensive Income

(In thousands)

(Unaudited)

 

     Three Months Ended
September 30,
     Nine Months Ended
September 30,
 
     2015      2014      2015      2014  

Total comprehensive income

   $ 119,704       $ 58,400       $ 371,699       $ 356,228   
  

 

 

    

 

 

    

 

 

    

 

 

 

See accompanying notes.

 

3


Table of Contents

AMETEK, Inc.

Consolidated Balance Sheet

(In thousands)

 

     September 30,
2015
    December 31,
2014
 
     (Unaudited)        

ASSETS

    

Current assets:

    

Cash and cash equivalents

   $ 328,034      $ 377,615   

Receivables, less allowance for possible losses

     610,019        585,462   

Inventories, net

     541,994        495,896   

Deferred income taxes

     40,231        45,053   

Other current assets

     70,462        74,578   
  

 

 

   

 

 

 

Total current assets

     1,590,740        1,578,604   

Property, plant and equipment, net

     483,029        448,446   

Goodwill

     2,722,871        2,614,030   

Other intangibles, net of accumulated amortization

     1,699,252        1,625,561   

Investments and other assets

     148,132        154,322   
  

 

 

   

 

 

 

Total assets

   $ 6,644,024      $ 6,420,963   
  

 

 

   

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

    

Current liabilities:

    

Short-term borrowings and current portion of long-term debt

   $ 295,259      $ 286,201   

Accounts payable

     375,187        386,207   

Income taxes payable

     20,671        27,157   

Accrued liabilities

     234,360        236,579   
  

 

 

   

 

 

 

Total current liabilities

     925,477        936,144   

Long-term debt

     1,621,812        1,427,825   

Deferred income taxes

     627,376        618,385   

Other long-term liabilities

     154,090        199,048   
  

 

 

   

 

 

 

Total liabilities

     3,328,755        3,181,402   
  

 

 

   

 

 

 

Stockholders’ equity:

    

Common stock

     2,607        2,589   

Capital in excess of par value

     559,060        491,750   

Retained earnings

     3,859,394        3,469,923   

Accumulated other comprehensive loss

     (349,213 )     (266,894

Treasury stock

     (756,579 )     (457,807
  

 

 

   

 

 

 

Total stockholders’ equity

     3,315,269        3,239,561   
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 6,644,024      $ 6,420,963   
  

 

 

   

 

 

 

See accompanying notes.

 

4


Table of Contents

AMETEK, Inc.

Condensed Consolidated Statement of Cash Flows

(In thousands)

(Unaudited)

 

     Nine Months Ended
September 30,
 
     2015     2014  

Cash provided by (used for):

    

Operating activities:

    

Net income

   $ 454,018     $ 432,460  

Adjustments to reconcile net income to total operating activities:

    

Depreciation and amortization

     110,031       102,800  

Deferred income taxes

     (5,200 )     (346

Share-based compensation expense

     17,679        15,055   

Gain on sale of facility

     —          (869

Net change in assets and liabilities, net of acquisitions

     (51,570     (32,720

Pension contribution

     (52,353     (2,583

Other

     537       (1,143
  

 

 

   

 

 

 

Total operating activities

     473,142        512,654   
  

 

 

   

 

 

 

Investing activities:

    

Additions to property, plant and equipment

     (45,293     (47,279

Purchases of businesses, net of cash acquired

     (356,466     (573,647

Proceeds from sale of facilities

     421        950   

Other

     (558     2,392   
  

 

 

   

 

 

 

Total investing activities

     (401,896     (617,584
  

 

 

   

 

 

 

Financing activities:

    

Net change in short-term borrowings

     160,231        (262,943

Additional long-term borrowings

     200,000        500,000   

Reduction in long-term borrowings

     (146,890     (533

Repurchases of common stock

     (306,525     (1,885

Cash dividends paid

     (64,661     (58,726

Excess tax benefits from share-based payments

     19,817        6,279   

Proceeds from employee stock plans and other

     36,909        11,743   
  

 

 

   

 

 

 

Total financing activities

     (101,119     193,935   
  

 

 

   

 

 

 

Effect of exchange rate changes on cash and cash equivalents

     (19,708     (14,595
  

 

 

   

 

 

 

(Decrease) increase in cash and cash equivalents

     (49,581     74,410   

Cash and cash equivalents:

    

As of January 1

     377,615        295,203   
  

 

 

   

 

 

 

As of September 30

   $ 328,034      $ 369,613   
  

 

 

   

 

 

 

See accompanying notes.

 

5


Table of Contents

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2015

(Unaudited)

 

1. Basis of Presentation

The accompanying consolidated financial statements are unaudited. AMETEK, Inc. (the “Company”) believes that all adjustments (which primarily consist of normal recurring accruals) necessary for a fair presentation of the consolidated financial position of the Company at September 30, 2015, and the consolidated results of its operations for the three and nine months ended September 30, 2015 and 2014 and its cash flows for the nine months ended September 30, 2015 and 2014 have been included. Quarterly results of operations are not necessarily indicative of results for the full year. The accompanying consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014 as filed with the U.S. Securities and Exchange Commission.

 

2. Recent Accounting Pronouncements

In April 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (“ASU 2014-08”). ASU 2014-08 revised guidance to only allow disposals of components of an entity that represent a strategic shift (e.g., disposal of a major geographical area, a major line of business, a major equity method investment, or other major parts of an entity) and that have a major effect on a reporting entity’s operations and financial results to be reported as discontinued operations. The revised guidance also requires expanded disclosure in the financial statements for discontinued operations as well as for disposals of significant components of an entity that do not qualify for discontinued operations presentation. The Company adopted ASU 2013-08 effective January 1, 2015 and the adoption did not have an impact on the Company’s consolidated results of operations, financial position or cash flows.

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”). The objective of ASU 2014-09 is to establish a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and will supersede most of the existing revenue recognition guidance. The core principle of ASU 2014-09 is that an entity recognizes revenue at the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In applying the new guidance, the Company must (1) identify the contract(s) with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the contract’s performance obligations; and (5) recognize revenue when the Company satisfies a performance obligation. ASU 2014-09 applies to all contracts with customers except those that are within the scope of other topics in the FASB Accounting Standards Codification. ASU 2014-09 is effective for interim and annual reporting periods beginning after December 15, 2017 and can be adopted by the Company using either a full retrospective or modified retrospective approach. ASU 2014-09 may be early adopted for interim and annual reporting periods beginning after December 15, 2016. The Company continues to evaluate the impacts and monitor the developments related to ASU 2014-09. The Company is in the process of determining the impact ASU 2014-09 may have on the Company’s consolidated results of operations, financial position or cash flows and has not decided upon the method of adoption.

In February 2015, the FASB issued ASU No. 2015-02, Amendments to the Consolidation Analysis (“ASU 2015-02”). ASU 2015-02 is intended to improve targeted areas of consolidation guidance for legal entities such as limited partnerships, limited liability corporations, and securitization structures (collateralized debt obligations, collateralized loan obligations, and mortgage-backed security transactions). ASU 2015-02 makes specific amendments to the current consolidation guidance and ends the deferral granted to investment companies from applying the variable interest entities guidance. ASU 2014-02 is effective for interim and annual reporting periods beginning after December 15, 2015. The Company does not expect the adoption of ASU 2015-02 to have a significant impact on the Company’s consolidated results of operations, financial position or cash flows.

In April 2015, the FASB issued ASU No. 2015-03, Simplifying the Presentation of Debt Issuance Costs (“ASU 2015-03”). ASU 2015-03 requires debt issuance costs to be presented in the balance sheet as a direct deduction from the associated debt liability. ASU 2015-03 is effective for interim and annual reporting periods beginning after December 15, 2015. The new guidance will be applied on a retrospective basis and early adoption is permitted. The Company does not expect the adoption of ASU 2015-03 to have a significant impact on the Company’s consolidated results of operations, financial position or cash flows.

 

6


Table of Contents

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2015

(Unaudited)

 

In April 2015, the FASB issued ASU No. 2015-05, Customer’s Accounting for Fees Paid in a Cloud Computing Arrangement (“ASU 2015-05”). ASU 2015-05 is intended to help entities evaluate the accounting for fees paid by a customer in a cloud computing arrangement. The guidance clarifies that customers should determine whether a cloud computing arrangement includes the license of software by applying the same guidance cloud service providers use to make this determination. For public business entities, the amendments will be effective for annual periods, including interim periods within those annual periods, beginning after December 15, 2015. Early adoption is permitted for all entities. An entity can elect to adopt the amendments either (1) prospectively to all arrangements entered into or materially modified after the effective date or (2) retrospectively. The Company has not determined the impact ASU 2015-05 may have on the Company’s consolidated results of operations, financial position or cash flows and has not decided upon the method of adoption.

In September 2015, the FASB issued ASU No. 2015-16, Simplifying the Accounting for Measurement-Period Adjustments (“ASU 2015-16”). ASU 2015-16 eliminates the requirement for an acquirer in a business combination to account for measurement-period adjustments retrospectively. Instead, acquirers must recognize measurement-period adjustments during the period in which they determine the amounts, including the effect on earnings of any amounts they would have recorded in previous periods if the accounting had been completed at the acquisition date. ASU 2015-16 is effective for interim and annual reporting periods beginning after December 15, 2016, with early adoption permitted. The Company does not expect the adoption of ASU 2015-16 to have a significant impact on the Company’s consolidated results of operations, financial position or cash flows.

 

3. Earnings Per Share

The calculation of basic earnings per share is based on the weighted average number of common shares considered outstanding during the periods. The calculation of diluted earnings per share reflects the effect of all potentially dilutive securities (principally outstanding stock options and restricted stock grants). The number of weighted average shares used in the calculation of basic earnings per share and diluted earnings per share was as follows:

 

     Three Months Ended
September 30,
     Nine Months Ended
September 30,
 
     2015      2014      2015      2014  
            (In thousands)         

Weighted average shares:

           

Basic shares

     239,959         245,439         240,801         245,184  

Equity-based compensation plans

     1,279         2,204         1,751         2,241  
  

 

 

    

 

 

    

 

 

    

 

 

 

Diluted shares

     241,238         247,643         242,552         247,425  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

4. Accumulated Other Comprehensive Income (Loss)

The components of accumulated other comprehensive income (loss) consisted of the following:

 

     Three Months Ended
September 30, 2015
    Three Months Ended
September 30, 2014
 
     Foreign
Currency
Items
and Other
    Defined
Benefit
Pension
Plans
    Total     Foreign
Currency
Items and
Other
    Defined
Benefit
Pension
Plans
    Total  
                 (In thousands)              

Balance at the beginning of the period

   $ (173,373   $ (139,146   $ (312,519   $ 4,668      $ (62,728   $ (58,060
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive income (loss) before reclassifications:

            

Translation adjustments

     (34,410     —          (34,410     (39,899     —          (39,899

Change in long-term intercompany notes

     (780     —          (780     (37,018     —          (37,018

Net investment hedges

     (4,497     —          (4,497     (11,021     —          (11,021

Gross amounts reclassified from accumulated other comprehensive income (loss)

     —          2,160        2,160        —          1,030        1,030   

Income tax benefit (expense)

     1,575        (742     833        3,857        (360     3,497   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive (loss) income, net of tax

     (38,112     1,418        (36,694     (84,081     670        (83,411
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance at the end of the period

   $ (211,485   $ (137,728   $ (349,213   $ (79,413   $ (62,058   $ (141,471
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

7


Table of Contents

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2015

(Unaudited)

 

     Nine Months Ended
September 30, 2015
    Nine Months Ended
September 30, 2014
 
     Foreign
Currency
Items
and Other
    Defined
Benefit
Pension
Plans
    Total     Foreign
Currency
Items and
Other
    Defined
Benefit
Pension
Plans
    Total  
                 (In thousands)              

Balance at the beginning of the period

   $ (124,912   $ (141,982   $ (266,894   $ (1,171   $ (64,068   $ (65,239
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive income (loss) before reclassifications:

            

Translation adjustments

     (41,066     —          (41,066     (35,540     —          (35,540

Change in long-term intercompany notes

     (40,825     —          (40,825     (38,154     —          (38,154

Net investment hedges

     (7,204     —          (7,204     (6,997     —          (6,997

Gross amounts reclassified from accumulated other comprehensive income (loss)

     —          6,480        6,480        —          3,092        3,092   

Income tax benefit (expense)

     2,522        (2,226     296        2,449        (1,082     1,367   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive (loss) income, net of tax

     (86,573     4,254        (82,319     (78,242     2,010        (76,232
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance at the end of the period

   $ (211,485   $ (137,728   $ (349,213   $ (79,413   $ (62,058   $ (141,471
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Reclassifications for the amortization of defined benefit pension plans are included in Cost of sales, excluding depreciation in the consolidated statement of income. See Note 13 for further details.

 

5. Fair Value Measurements

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.

The Company utilizes a valuation hierarchy for disclosure of the inputs to the valuations used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on the Company’s own assumptions used to measure assets and liabilities at fair value. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.

The following table provides the Company’s assets that are measured at fair value on a recurring basis as of September 30, 2015 and December 31, 2014, consistent with the fair value hierarchy:

 

     September 30, 2015      December 31, 2014  
     Fair Value      Fair Value  
     (In thousands)  

Fixed-income investments

   $ 8,487       $ 9,219   

The fair value of fixed-income investments, which are valued as level 1 investments, was based on quoted market prices. The fixed-income investments are shown as a component of long-term assets on the consolidated balance sheet.

For the nine months ended September 30, 2015, gains and losses on the investments noted above were not significant. No transfers between level 1 and level 2 investments occurred during the nine months ended September 30, 2015.

 

8


Table of Contents

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2015

(Unaudited)

 

Financial Instruments

Cash, cash equivalents and fixed-income investments are recorded at fair value at September 30, 2015 and December 31, 2014 in the accompanying consolidated balance sheet.

The following table provides the estimated fair values of the Company’s financial instrument liabilities, for which fair value is measured for disclosure purposes only, compared to the recorded amounts at September 30, 2015 and December 31, 2014:

 

     September 30, 2015      December 31, 2014  
     Recorded
Amount
     Fair Value      Recorded
Amount
     Fair Value  
     (In thousands)  

Short-term borrowings

   $ (257,300    $ (257,300    $ (88,100    $ (88,100

Long-term debt (including current portion)

     (1,659,771      (1,746,242      (1,625,926      (1,768,439

The fair value of short-term borrowings approximates the carrying value. Short-term borrowings are valued as level 2 investments as they are corroborated by observable market data. The Company’s long-term debt is all privately held with no public market for this debt, therefore, the fair value of long-term debt was computed based on comparable current market data for similar debt instruments and is considered to be a level 3 liability.

 

6. Hedging Activities

The Company has designated certain foreign-currency-denominated long-term borrowings as hedges of the net investment in certain foreign operations. As of September 30, 2015, these net investment hedges included British-pound-denominated long-term debt. As of December 31, 2014, these net investment hedges included British-pound-denominated long-term debt and Euro-denominated short-term debt. These borrowings were designed to create net investment hedges in each of the designated foreign subsidiaries. The Company designated the British-pound- and Euro-denominated loans referred to above as hedging instruments to offset translation gains or losses on the net investment due to changes in the British pound and Euro exchange rates. These net investment hedges are evidenced by management’s contemporaneous documentation supporting the hedge designation. Any gain or loss on the hedging instrument (the debt) following hedge designation is reported in accumulated other comprehensive income in the same manner as the translation adjustment on the investment based on changes in the spot rate, which is used to measure hedge effectiveness.

At September 30, 2015 and December 31, 2014, the Company had $181.4 million and $186.7 million, respectively, of British-pound-denominated loans, which were designated as a hedge against the net investment in British pound functional currency foreign subsidiaries. In the third quarter of 2015, the Company paid in full, at maturity, a 50 million Euro ($56.4 million) loan, which was designated as a hedge against the net investment in Euro functional currency foreign subsidiaries. See Note 11 for further details. At December 31, 2014, the Company had a $60.8 million Euro-denominated loan, which was designated as a hedge against the net investment in Euro functional currency foreign subsidiaries. As a result of these British-pound- and Euro-denominated loans being designated and 100% effective as net investment hedges, $10.2 million of currency remeasurement gains have been included in the foreign currency translation component of other comprehensive income for the nine months ended September 30, 2015.

 

7. Inventories

 

     September 30,
2015
     December 31,
2014
 
     (In thousands)  

Finished goods and parts

   $ 81,853       $ 80,307   

Work in process

     115,358         94,298   

Raw materials and purchased parts

     344,783         321,291   
  

 

 

    

 

 

 

Total inventories

   $ 541,994       $ 495,896   
  

 

 

    

 

 

 

 

9


Table of Contents

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2015

(Unaudited)

 

8. Acquisitions

The Company spent $356.5 million in cash, net of cash acquired, to acquire Global Tubes in May 2015 and Surface Vision, formerly referred to as the Surface Inspection Systems Division of Cognex Corporation, in July 2015. Global Tubes is a manufacturer of high precision, small diameter metal tubing. Surface Vision develops and manufactures software-enabled vision systems used to inspect surfaces of continuously processed materials for flaws and defects. Global Tubes is part of AMETEK’s Electromechanical Group (“EMG”) and Surface Vision is part of AMETEK’s Electronic Instruments Group (“EIG”).

The following table represents the preliminary allocation of the aggregate purchase price for the net assets of the above acquisitions based on their estimated fair values at acquisition (in millions):

 

Property, plant and equipment

   $ 53.4   

Goodwill

     155.2   

Other intangible assets

     156.8   

Deferred income taxes

     (25.4

Net working capital and other*

     16.5   
  

 

 

 

Total purchase price

   $ 356.5   
  

 

 

 

 

* Includes $29.0 million in accounts receivable, whose fair value, contractual cash flows and expected cash flows are approximately equal.

The amount allocated to goodwill is reflective of the benefits the Company expects to realize from the acquisitions as follows: Global Tubes’ metallurgical capabilities, processing capabilities and alloy ranges are complementary and expand the Company’s product offerings in highly engineered applications serving the aerospace, energy, power generation and medical markets. Surface Vision’s proprietary real-time image processing technology broadens the Company’s capabilities in the non-destructive process inspection market. The Company does not expect any of the goodwill recorded in connection with the Global Tubes acquisition to be tax deductible in future years. The Company expects approximately $67.8 million of the goodwill recorded in connection with the Surface Vision acquisition will be tax deductible in future years.

At September 30, 2015, purchase price allocated to other intangible assets of $156.8 million consists of $20.6 million of indefinite-lived intangible trademarks and trade names, which are not subject to amortization. The remaining $136.2 million of other intangible assets consists of $85.1 million of customer relationships, which are being amortized over a period of 18 to 20 years, $13.1 million of trade names, which are being amortized over a period of two to 14 years and $38.0 million of purchased technology, which is being amortized over a period of 15 to 20 years. Amortization expense for each of the next five years for the 2015 acquisitions listed above is expected to approximate $8.0 million per year.

The Company recognized $8.4 million in environmental liabilities related to the estimated costs to remediate known environmental issues at Global Tubes. The $8.4 million is included in net working capital and other in the table above.

The Company is in the process of finalizing the measurement of certain tangible and intangible assets and liabilities for its 2015 acquisitions, including the environmental liabilities noted above, goodwill, customer relationships, trade names, purchased technology and the accounting for income taxes.

The 2015 acquisitions noted above had an immaterial impact on reported net sales, net income and diluted earnings per share for the three and nine months ended September 30, 2015. Had the 2015 acquisitions been made at the beginning of 2015 or 2014, unaudited pro forma net sales, net income and diluted earnings per share for the three and nine months ended September 30, 2015 and 2014, respectively, would not have been materially different than the amounts reported. Pro forma results are not necessarily indicative of the results that would have occurred if the acquisitions had been completed at the beginning of 2015 or 2014.

 

10


Table of Contents

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2015

(Unaudited)

 

9. Goodwill

The changes in the carrying amounts of goodwill by segment were as follows:

 

     Electronic
Instruments
Group
     Electro-
mechanical
Group
     Total  
     (In millions)  

Balance at December 31, 2014

   $ 1,646.7       $ 967.3       $ 2,614.0   

Goodwill acquired

     67.8         87.4         155.2   

Purchase price allocation adjustments and other

     (3.8      —           (3.8

Foreign currency translation adjustments

     (23.7      (18.8      (42.5
  

 

 

    

 

 

    

 

 

 

Balance at September 30, 2015

   $ 1,687.0       $ 1,035.9       $ 2,722.9   
  

 

 

    

 

 

    

 

 

 

 

10. Income Taxes

At September 30, 2015, the Company had gross unrecognized tax benefits of $62.3 million, of which $51.7 million, if recognized, would impact the effective tax rate.

The following is a reconciliation of the liability for uncertain tax positions (in millions):

 

Balance at December 31, 2014

   $ 71.7   

Additions for tax positions

     10.7   

Reductions for tax positions

     (20.1
  

 

 

 

Balance at September 30, 2015

   $ 62.3   
  

 

 

 

The Company recognizes interest and penalties accrued related to uncertain tax positions in income tax expense. The amounts recognized in income tax expense for interest and penalties during the three and nine months ended September 30, 2015 and 2014 were not significant.

 

11. Debt

In August 2015, the Company obtained the third funding of $150 million, consisting of $100 million in aggregate principal amount of 3.96% senior notes due August 2025 and $50 million in aggregate principal amount of 4.45% senior notes due August 2035 under the third quarter of 2014 private placement agreement. In June 2015, the Company obtained the second funding of $50 million in aggregate principal amount of 3.91% senior notes due June 2025 under the third quarter of 2014 private placement agreement. The first funding occurred in September 2014 for $500 million, consisting of $300 million in aggregate principal amount of 3.73% senior notes due September 2024, $100 million in aggregate principal amount of 3.83% senior notes due September 2026 and $100 million in aggregate principal amount of 3.98% senior notes due September 2029. The senior notes carry a weighted average interest rate of 3.88%. The senior notes are subject to certain customary covenants, including financial covenants that, among other things, require the Company to maintain certain debt to EBITDA (earnings before interest, income taxes, depreciation and amortization) and interest coverage ratios. The proceeds from the third funding of the senior notes were used to pay down senior notes that matured in the third quarter of 2015 described further below. The proceeds from the second funding of the senior notes were used to pay down domestic borrowings under the Company’s revolving credit facility.

In the third quarter of 2015, the Company paid in full, at maturity, $90 million in aggregate principal amount of 6.59% private placement senior notes and 50 million Euro ($56.4 million) 3.94% senior note.

 

11


Table of Contents

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2015

(Unaudited)

 

12. Share-Based Compensation

The fair value of each stock option grant is estimated on the date of grant using a Black-Scholes-Merton option pricing model. The following weighted average assumptions were used in the Black-Scholes-Merton model to estimate the fair values of stock options granted during the years indicated:

 

     Nine Months  Ended
September 30, 2015
    Year Ended
December 31, 2014
 

Expected volatility

     22.3     23.9

Expected term (years)

     5.0        5.0  

Risk-free interest rate

     1.58     1.63

Expected dividend yield

     0.69     0.45

Black-Scholes-Merton fair value per stock option granted

   $ 10.89      $ 12.21   

Expected volatility is based on the historical volatility of the Company’s stock. The Company used historical exercise data to estimate the stock options’ expected term, which represents the period of time that the stock options granted are expected to be outstanding. Management anticipates that the future stock option holding periods will be similar to the historical stock option holding periods. The risk-free interest rate for periods within the contractual life of the stock option is based on the U.S. Treasury yield curve at the time of grant. Compensation expense recognized for all share-based awards is net of estimated forfeitures. The Company’s estimated forfeiture rates are based on its historical experience.

Total share-based compensation expense was as follows:

 

     Three Months Ended
September 30,
     Nine Months Ended
September 30,
 
     2015      2014      2015      2014  
     (In thousands)  

Stock option expense

   $ 2,279       $ 1,887       $ 8,466       $ 7,227   

Restricted stock expense

     3,321         2,860         9,213         7,828   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total pre-tax expense

     5,600         4,747         17,679         15,055   

Related tax benefit

     (1,779      (1,423      (5,805      (4,710
  

 

 

    

 

 

    

 

 

    

 

 

 

Reduction of net income

   $ 3,821       $ 3,324       $ 11,874       $ 10,345   
  

 

 

    

 

 

    

 

 

    

 

 

 

Pre-tax share-based compensation expense is included in the consolidated statement of income in either Cost of sales, excluding depreciation or Selling, general and administrative expenses, depending on where the recipient’s cash compensation is reported.

The following is a summary of the Company’s stock option activity and related information:

 

     Shares      Weighted
Average
Exercise

Price
     Weighted
Average
Remaining
Contractual

Life
     Aggregate
Intrinsic

Value
 
     (In thousands)             (Years)      (In millions)  

Outstanding at December 31, 2014

     6,362       $ 31.47         

Granted

     1,326         52.30         

Exercised

     (1,808      20.66         

Forfeited

     (115      46.57         

Expired

     (4      48.89         
  

 

 

          

Outstanding at September 30, 2015

     5,761       $ 39.35         4.3       $ 75.5   
  

 

 

    

 

 

    

 

 

    

 

 

 

Exercisable at September 30, 2015

     2,984       $ 30.60         2.9       $ 65.0   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

12


Table of Contents

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2015

(Unaudited)

 

The aggregate intrinsic value of stock options exercised during the nine months ended September 30, 2015 was $60.0 million. The total fair value of stock options vested during the nine months ended September 30, 2015 was $9.9 million. As of September 30, 2015, there was approximately $20.5 million of expected future pre-tax compensation expense related to the 2.8 million nonvested stock options outstanding, which is expected to be recognized over a weighted average period of approximately two years.

The following is a summary of the Company’s nonvested restricted stock activity and related information:

 

     Shares      Weighted
Average
Grant Date
Fair Value
 
     (In thousands)         

Nonvested restricted stock outstanding at December 31, 2014

     1,105       $ 41.08   

Granted

     335         52.30   

Vested

     (294      33.40   

Forfeited

     (58      44.62   
  

 

 

    

Nonvested restricted stock outstanding at September 30, 2015

     1,088       $ 46.34   
  

 

 

    

 

 

 

The total fair value of restricted stock vested during the nine months ended September 30, 2015 was $9.8 million. As of September 30, 2015, there was approximately $31.6 million of expected future pre-tax compensation expense related to the 1.1 million nonvested restricted shares outstanding, which is expected to be recognized over a weighted average period of approximately two years.

 

13. Retirement and Pension Plans

The components of net periodic pension benefit expense (income) were as follows:

 

     Three Months Ended
September 30,
     Nine Months Ended
September 30,
 
     2015      2014      2015      2014  
     (In thousands)  

Defined benefit plans:

           

Service cost

   $ 1,831       $ 1,630       $ 5,380       $ 4,910   

Interest cost

     7,304         7,237         21,084         21,732   

Expected return on plan assets

     (14,017      (12,582      (40,690      (37,749

Amortization of net actuarial loss and other

     2,160         1,030         6,480         3,092   
  

 

 

    

 

 

    

 

 

    

 

 

 

Pension income

     (2,722      (2,685      (7,746      (8,015
  

 

 

    

 

 

    

 

 

    

 

 

 

Other plans:

           

Defined contribution plans

     5,225         5,163         17,725         15,888   

Foreign plans and other

     1,230         1,397         3,716         4,169   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total other plans

     6,455         6,560         21,441         20,057   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total net pension expense

   $ 3,733       $ 3,875       $ 13,695       $ 12,042   
  

 

 

    

 

 

    

 

 

    

 

 

 

For the nine months ended September 30, 2015 and 2014, contributions to the Company’s defined benefit pension plans were $52.4 million and $2.6 million, respectively. The Company’s current estimate of 2015 contributions to its worldwide defined benefit pension plans is in line with the range disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014.

 

13


Table of Contents

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2015

(Unaudited)

 

14. Product Warranties

The Company provides limited warranties in connection with the sale of its products. The warranty periods for products sold vary widely among the Company’s operations, but for the most part do not exceed one year. The Company calculates its warranty expense provision based on past warranty experience and adjustments are made periodically to reflect actual warranty expenses.

Within the product warranty table below, the nine months ended September 30, 2014 has been adjusted to disclose gross accruals for warranties issued during the period and gross settlements made during the period to conform to the current period presentation.

Changes in the accrued product warranty obligation were as follows:

 

     Nine Months Ended
September 30,
 
     2015      2014  
     (In thousands)  

Balance at the beginning of the period

   $ 29,764       $ 28,036   

Accruals for warranties issued during the period

     8,826         11,618   

Settlements made during the period

     (13,798      (13,657

Warranty accruals related to acquired businesses and other during the period

     (1,672      3,268   
  

 

 

    

 

 

 

Balance at the end of the period

   $ 23,120       $ 29,265   
  

 

 

    

 

 

 

Certain settlements of warranties made during the period were for specific nonrecurring warranty obligations. Product warranty obligations are reported as current liabilities in the consolidated balance sheet.

 

15. Contingencies

Asbestos Litigation

The Company (including its subsidiaries) has been named as a defendant, along with many other companies, in a number of asbestos-related lawsuits. Many of these lawsuits either relate to businesses which were acquired by the Company and do not involve products which were manufactured or sold by the Company or relate to previously owned businesses of the Company which are under new ownership. In connection with many of these lawsuits, the sellers or new owners of such businesses, as the case may be, have agreed to indemnify the Company against these claims (the “Indemnified Claims”). The Indemnified Claims have been tendered to, and are being defended by, such sellers and new owners. These sellers and new owners have met their obligations, in all respects, and the Company does not have any reason to believe such parties would fail to fulfill their obligations in the future; however, one of these companies filed for bankruptcy liquidation in 2007. To date, no judgments have been rendered against the Company as a result of any asbestos-related lawsuit. The Company believes it has strong defenses to the claims being asserted and intends to continue to vigorously defend itself in these matters.

 

14


Table of Contents

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2015

(Unaudited)

 

Environmental Matters

Certain historic processes in the manufacture of products have resulted in environmentally hazardous waste by-products as defined by federal and state laws and regulations. At September 30, 2015, the Company is named a Potentially Responsible Party (“PRP”) at 14 non-AMETEK-owned former waste disposal or treatment sites (the “non-owned” sites). The Company is identified as a “de minimis” party in 13 of these sites based on the low volume of waste attributed to the Company relative to the amounts attributed to other named PRPs. In nine of these sites, the Company has reached a tentative agreement on the cost of the de minimis settlement to satisfy its obligation and is awaiting executed agreements. The tentatively agreed-to settlement amounts are fully reserved. In the other four sites, the Company is continuing to investigate the accuracy of the alleged volume attributed to the Company as estimated by the parties primarily responsible for remedial activity at the sites to establish an appropriate settlement amount. At the remaining site where the Company is a non-de minimis PRP, the Company is participating in the investigation and/or related required remediation as part of a PRP Group and reserves have been established sufficient to satisfy the Company’s expected obligations. The Company historically has resolved these issues within established reserve levels and reasonably expects this result will continue. In addition to these non-owned sites, the Company has an ongoing practice of providing reserves for probable remediation activities at certain of its current or previously owned manufacturing locations (the “owned” sites). For claims and proceedings against the Company with respect to other environmental matters, reserves are established once the Company has determined that a loss is probable and estimable. This estimate is refined as the Company moves through the various stages of investigation, risk assessment, feasibility study and corrective action processes. In certain instances, the Company has developed a range of estimates for such costs and has recorded a liability based on the low end of the range. It is reasonably possible that the actual cost of remediation of the individual sites could vary from the current estimates and the amounts accrued in the consolidated financial statements; however, the amounts of such variances are not expected to result in a material change to the consolidated financial statements. In estimating the Company’s liability for remediation, the Company also considers the likely proportionate share of the anticipated remediation expense and the ability of the other PRPs to fulfill their obligations.

Total environmental reserves at September 30, 2015 and December 31, 2014 were $32.0 million and $26.6 million, respectively, for both non-owned and owned sites. For the nine months ended September 30, 2015, the Company recorded $9.2 million in reserves, of which $8.4 million was related to a 2015 business acquisition. These reserves relate to the estimated costs to remediate known environmental issues associated with the acquired business. Additionally, the Company spent $3.8 million on environmental matters for the nine months ended September 30, 2015. The Company’s reserves for environmental liabilities at September 30, 2015 and December 31, 2014 include reserves of $11.6 million and $11.7 million, respectively, for an owned site acquired in connection with the 2005 acquisition of HCC Industries (“HCC”). The Company is the designated performing party for the performance of remedial activities for one of several operating units making up a Superfund site in the San Gabriel Valley of California. The Company has obtained indemnifications and other financial assurances from the former owners of HCC related to the costs of the required remedial activities. At September 30, 2015, the Company had $10.0 million in receivables related to HCC for probable recoveries from third-party escrow funds and other committed third-party funds to support the required remediation. Also, the Company is indemnified by HCC’s former owners for approximately $19.0 million of additional costs.

The Company has agreements with other former owners of certain of its acquired businesses, as well as new owners of previously owned businesses. Under certain of the agreements, the former or new owners retained, or assumed and agreed to indemnify the Company against, certain environmental and other liabilities under certain circumstances. The Company and some of these other parties also carry insurance coverage for some environmental matters. To date, these parties have met their obligations in all material respects.

The Company believes it has established reserves which are sufficient to perform all known responsibilities under existing claims and consent orders. The Company has no reason to believe that other third parties would fail to perform their obligations in the future. In the opinion of management, based upon presently available information and past experience related to such matters, an adequate provision for probable costs has been made and the ultimate cost resulting from these actions is not expected to materially affect the consolidated results of operations, financial position or cash flows of the Company.

 

15


Table of Contents

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2015

(Unaudited)

 

16. First Quarter of 2015 Restructuring Charges

During the first quarter of 2015, the Company recorded pre-tax restructuring charges totaling $15.9 million, which had the effect of reducing net income by $10.8 million ($0.04 per diluted share). The restructuring charges were reported in the consolidated statement of income as follows: $15.8 million in Cost of sales, excluding depreciation and $0.1 million in Selling, general and administrative expenses. The restructuring charges were reported in segment operating income as follows: $9.3 million in EIG, $6.5 million in EMG and $0.1 million in corporate administrative expenses. The restructuring costs primarily related to a reduction in workforce in response to the effects of a continued strong U.S. dollar and a weak global economy on certain of our businesses. The restructuring activities have been broadly implemented across the Company’s various businesses with all actions expected to be completed by the first half of 2016.

Accrued liabilities in the Company’s consolidated balance sheet included amounts related to the first quarter of 2015 restructuring charges as follows (in millions):

 

Balance at December 31, 2014

   $ —     

Pre-tax charges

     15.9   

Utilization

     (8.2

Foreign currency translation and other

     0.1   
  

 

 

 

Balance at September 30, 2015

   $ 7.8   
  

 

 

 

 

17. Stockholders’ Equity

On April 1, 2015, the Company’s Board of Directors approved an increase of $350 million in the authorization for repurchase of the Company’s common stock. For the nine months ended September 30, 2015, the Company repurchased approximately 5,576,000 shares of common stock for $306.5 million in cash under its share repurchase authorization. At September 30, 2015, $90.6 million was available under the Company’s Board of Directors authorization for future share repurchases. On November 4, 2015, the Company’s Board of Directors approved an increase of $350 million in the authorization for repurchase of the Company’s common stock.

 

18. Reportable Segments

The Company has two reportable segments, Electronic Instruments Group and Electromechanical Group. The Company’s operating units are identified based on the existence of segment managers. Certain of the Company’s operating units have been aggregated for segment reporting purposes primarily on the basis of product type, production processes, distribution methods and similarity of economic characteristics.

At September 30, 2015, there were no significant changes in identifiable assets of reportable segments from the amounts disclosed at December 31, 2014, other than those described in the acquisitions footnote (Note 8), nor were there any significant changes in the basis of segmentation or in the measurement of segment operating results. Operating information relating to the Company’s reportable segments for the three and nine months ended September 30, 2015 and 2014 can be found in the table included in Part I, Item 2. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of this Quarterly Report on Form 10-Q.

 

16


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Results of Operations

The following table sets forth net sales and income by reportable segment and on a consolidated basis:

 

     Three Months Ended      Nine Months Ended  
     September 30,      September 30,  
     2015      2014      2015      2014  
     (In thousands)  

Net sales(1):

           

Electronic Instruments

   $ 598,515       $ 631,569       $ 1,788,777       $ 1,777,252   

Electromechanical

     400,012         400,242         1,197,535         1,220,569   
  

 

 

    

 

 

    

 

 

    

 

 

 

Consolidated net sales

   $ 998,527       $ 1,031,811       $ 2,986,312       $ 2,997,821   
  

 

 

    

 

 

    

 

 

    

 

 

 

Operating income and income before income taxes:

           

Segment operating income(2):

           

Electronic Instruments

   $ 162,530       $ 148,313       $ 477,740       $ 450,131   

Electromechanical

     86,671         82,001         257,929         258,014   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total segment operating income

     249,201         230,314         735,669         708,145   

Corporate administrative and other expenses

     (11,586      (12,171      (36,783      (36,643
  

 

 

    

 

 

    

 

 

    

 

 

 

Consolidated operating income

     237,615         218,143         698,886         671,502   

Interest and other expenses, net

     (26,009      (28,182      (75,346      (74,204
  

 

 

    

 

 

    

 

 

    

 

 

 

Consolidated income before income taxes

   $ 211,606       $ 189,961       $ 623,540       $ 597,298   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(1) After elimination of intra- and intersegment sales, which are not significant in amount.
(2) Segment operating income represents net sales less all direct costs and expenses (including certain administrative and other expenses) applicable to each segment, but does not include interest expense.

Results of operations for the third quarter of 2015 compared with the third quarter of 2014

For the quarter ended September 30, 2015, the Company established records for net income and diluted earnings per share. Contributions from the acquisitions of Surface Vision, formerly referred to as the Surface Inspection Systems Division of Cognex Corporation, in July 2015, Global Tubes in May 2015 and Amptek, Inc. in August 2014, as well as the Company’s Operational Excellence initiatives had a positive impact on the third quarter of 2015 results. The full year impact of the 2015 and 2014 acquisitions and continued focus on and implementation of Operational Excellence initiatives, including the first quarter of 2015 realignment of the Company’s operations (described further in the results of operations for the first nine months of 2015), are expected to have a positive impact on the remainder of the Company’s 2015 results. The Company expects the challenging global environment across many of its markets and geographies to continue for the remainder of the year, while a stronger U.S. dollar is expected to be a continued headwind in 2015.

Net sales for the third quarter of 2015 were $998.5 million, a decrease of $33.3 million or 3.2%, compared with net sales of $1,031.8 million for the third quarter of 2014. The net sales decrease was due to an unfavorable 4% effect of foreign currency translation and 2% internal sales decline, partially offset by a 2% increase from acquisitions.

Total international sales for the third quarter of 2015 were $504.7 million or 50.5% of net sales, a decrease of $43.2 million or 7.9%, compared with international sales of $547.9 million or 53.1% of net sales for the third quarter of 2014. The $43.2 million decrease in international sales was primarily driven by the foreign currency translation headwind noted above and the competitive impacts of a stronger U.S. dollar. Both reportable segments of the Company maintain strong international sales presences in Europe and Asia.

New orders for the third quarter of 2015 were $979.7 million, a decrease of $16.3 million or 1.6%, compared with $996.0 million for the third quarter of 2014. The decrease in orders for the third quarter of 2015 was due to internal order decline of approximately 5% and an unfavorable 1% effect of foreign currency translation, partially offset by a 4% increase from acquisitions.

 

17


Table of Contents

Results of Operations (continued)

 

Segment operating income for the third quarter of 2015 was $249.2 million, an increase of $18.9 million or 8.2%, compared with segment operating income of $230.3 million for the third quarter of 2014. The increase in segment operating income resulted primarily from the acquisitions mentioned above, as well as the benefits of the Company’s Operational Excellence initiatives. The third quarter of 2014 segment operating income included a $9.1 million severance charge and $4.5 million fair value inventory adjustment, both related to the 2014 acquisition of Zygo Corporation (“the Zygo integration costs”). Segment operating income, as a percentage of net sales, increased to 25.0% for the third quarter of 2015, compared with 22.3% for the third quarter of 2014. The increase in segment operating margins resulted primarily from the benefits of the Company’s Operational Excellence initiatives. The third quarter of 2014 segment operating margins were impacted by the Zygo integration costs noted above.

Cost of sales, excluding depreciation expense for the third quarter of 2015 was $631.8 million or 63.3% of net sales, a decrease of $45.9 million or 6.8%, compared with $677.7 million or 65.7% of net sales for the third quarter of 2014. The cost of sales, excluding depreciation expense decrease and the corresponding decrease in cost of sales, excluding depreciation expense as a percentage of sales were primarily due to cost containment initiatives, the impact of foreign currency translation, as well as the net sales decrease noted above. Cost of sales, excluding depreciation expense for the third quarter of 2014 included $13.7 million of Zygo integration costs.

Selling, general and administrative (“SG&A”) expenses for the third quarter of 2015 were $112.1 million, a decrease of $7.1 million or 6.0%, compared with $119.2 million for the third quarter of 2014. As a percentage of net sales, SG&A expenses were 11.2% for the third quarter of 2015, compared with 11.6% for the third quarter of 2014. Selling expenses for the third quarter of 2015 were $100.7 million, a decrease of $6.5 million or 6.1%, compared with $107.2 million for the third quarter of 2014. Selling expenses, as a percentage of net sales, decreased to 10.1% for the third quarter of 2015, compared with 10.4% for the third quarter of 2014. The selling expenses decrease and the corresponding decrease in selling expenses as a percentage of sales were primarily due to cost containment initiatives and the impact of foreign currency translation.

Corporate administrative expenses for the third quarter of 2015 were $11.5 million, a decrease of $0.6 million or 5.0%, compared with $12.1 million for the third quarter of 2014. As a percentage of net sales, corporate administrative expenses were 1.1% for the third quarter of 2015, compared with 1.2% for the third quarter of 2014.

Consolidated operating income was $237.6 million or 23.8% of net sales for the third quarter of 2015, an increase of $19.5 million or 8.9%, compared with $218.1 million or 21.1% of net sales for the third quarter of 2014.

Interest expense was $23.7 million for the third quarter of 2015, an increase of $4.2 million or 21.5%, compared with $19.5 million for the third quarter of 2014. The increase was due to the impact of private placement senior notes funded in the second and third quarters of 2015 and the third quarter of 2014.

Other expenses, net were $2.3 million for the third quarter of 2015, a decrease of $6.3 million, compared with $8.6 million for the third quarter of 2014. The third quarter of 2014 included a $5.5 million reversal of an insurance policy receivable related to a specific uncertain tax position liability of an acquired entity discussed further below.

The effective tax rate for the third quarter of 2015 was 26.1%, compared with 25.3% for the third quarter of 2014. The effective tax rates for the third quarter of 2015 and 2014 reflect the impact of foreign earnings, which are taxed at lower rates. The effective tax rate for the third quarter of 2015 reflects $7.5 million of tax benefits related to the closure of an international subsidiary. During the third quarter of 2014, due to the final closure of a tax year, the Company released $12.9 million of uncertain tax position liabilities related to an acquired entity. Partially offsetting this benefit during the third quarter of 2014 were tax costs related to certain international tax planning initiatives and the non-deductibility of an insurance policy receivable reversal and a portion of the third quarter Zygo severance charge, both discussed above.

Net income for the third quarter of 2015 was $156.4 million, an increase of $14.6 million or 10.3%, compared with $141.8 million for the third quarter of 2014. Diluted earnings per share for the third quarter of 2015 were $0.65, an increase of $0.08 or 14.0%, compared with $0.57 per diluted share for the third quarter of 2014.

 

18


Table of Contents

Results of Operations (continued)

 

Segment Results

Electronic Instruments Group’s (“EIG”) net sales totaled $598.5 million for the third quarter of 2015, a decrease of $33.1 million or 5.2%, compared with $631.6 million for the third quarter of 2014. The net sales decrease was due to an unfavorable 3% effect of foreign currency translation and 2% internal sales decline.

EIG’s operating income was $162.5 million for the third quarter of 2015, an increase of $14.2 million or 9.6%, compared with $148.3 million for the third quarter of 2014. EIG’s operating margins were 27.2% of net sales for the third quarter of 2015, compared with 23.5% of net sales for the third quarter of 2014. EIG’s increase in operating income and operating margins resulted from the benefits of the Group’s Operational Excellence initiatives. Also, EIG’s third quarter of 2014 operating income and operating margins included the Zygo integration costs noted above.

Electromechanical Group’s (“EMG”) net sales totaled $400.0 million for the third quarter of 2015, a decrease of $0.2 million or flat on a percentage basis, compared with $400.2 million for the third quarter of 2014. The net sales decrease was due to an unfavorable 4% effect of foreign currency translation and 2% internal sales decline, offset by a 6% increase from the acquisition of Global Tubes.

EMG’s operating income was $86.7 million for the third quarter of 2015, an increase of $4.7 million or 5.7%, compared with $82.0 million for the third quarter of 2014. EMG’s operating margins were 21.7% of net sales for the third quarter of 2015, compared with 20.5% of net sales for the third quarter of 2014. EMG’s increase in operating income and operating margins resulted primarily from the benefits of the Group’s Operational Excellence initiatives.

 

19


Table of Contents

Results of Operations (continued)

 

Results of operations for the first nine months of 2015 compared with the first nine months of 2014

Net sales for the first nine months of 2015 were $2,986.3 million, a decrease of $11.5 million or 0.4%, compared with net sales of $2,997.8 million for the first nine months of 2014. The net sales decrease was due to an unfavorable 4% effect of foreign currency translation, partially offset by a 4% increase from acquisitions. Internal sales growth was flat period over period.

Total international sales for the first nine months of 2015 were $1,528.2 million or 51.2% of net sales, a decrease of $118.3 million or 7.2%, compared with international sales of $1,646.5 million or 54.9% of net sales for the first nine months of 2014. The $118.3 million decrease in international sales was primarily driven by the foreign currency translation headwind noted above and the competitive impacts of a stronger U.S. dollar. Both reportable segments of the Company maintain strong international sales presences in Europe and Asia.

New orders for the first nine months of 2015 were $2,958.4 million, a decrease of $114.6 million or 3.7%, compared with $3,073.0 million for the first nine months of 2014. The decrease in orders for the first nine months of 2015 was due to an unfavorable 4% effect of foreign currency translation and internal order decline of approximately 2%, partially offset by a 2% increase from acquisitions. As a result, the Company’s backlog of unfilled orders at September 30, 2015 was $1,169.4 million, a decrease of $27.9 million or 2.3%, compared with $1,197.3 million at December 31, 2014, largely driven by unfavorable foreign currency translation.

Segment operating income for the first nine months of 2015 was $735.7 million, an increase of $27.6 million or 3.9%, compared with segment operating income of $708.1 million for the first nine months of 2014. The increase in segment operating income resulted primarily from the acquisitions mentioned above, as well as the benefits of the Company’s Operational Excellence initiatives. The first nine months of 2015 included pre-tax realignment costs totaling $15.9 million recorded in the first quarter of 2015, which were primarily related to employee severance. The expected annualized cash savings from this first quarter of 2015 realignment is expected to be approximately $55 million, with approximately $40 million expected to be realized in 2015. The first nine months of 2014 included $13.7 million of Zygo integration costs noted above. Segment operating income, as a percentage of net sales, increased to 24.6% for the first nine months of 2015, compared with 23.6% for the first nine months of 2014. The increase in segment operating margins resulted primarily from the benefits of the Company’s Operational Excellence initiatives. Segment operating margins for the first nine months of 2015 were negatively impacted by approximately 50 basis points due to the first quarter of 2015 realignment costs described above. Segment operating margins for the first nine months of 2014 were negatively impacted by approximately 50 basis points due to the Zygo integration costs described above.

Cost of sales, excluding depreciation expense for the first nine months of 2015 was $1,901.7 million or 63.7% of net sales, a decrease of $31.9 million or 1.6%, compared with $1,933.6 million or 64.5% of net sales for the first nine months of 2014. The cost of sales, excluding depreciation expense decrease and the corresponding decrease in cost of sales, excluding depreciation expense as a percentage of sales were primarily due to cost containment initiatives, the impact of foreign currency translation, as well as the net sales decrease noted above. Cost of sales, excluding depreciation expense for the first nine months of 2015 included pre-tax realignment costs totaling $15.8 million recorded in the first quarter of 2015. Cost of sales, excluding depreciation expense for the first nine months of 2014 included $13.7 million of Zygo integration costs recorded in the third quarter of 2014.

SG&A expenses for the first nine months of 2015 were $335.7 million, a decrease of $9.4 million or 2.7%, compared with $345.1 million for the first nine months of 2014. As a percentage of net sales, SG&A expenses were 11.2% for the first nine months of 2015, compared with 11.5% for the first nine months of 2014. Selling expenses for the first nine months of 2015 were $299.4 million, a decrease of $9.5 million or 3.1%, compared with $308.9 million for the first nine months of 2014. Selling expenses, as a percentage of net sales, decreased to 10.0% for the first nine months of 2015, compared with 10.3% for the first nine months of 2014. The selling expenses decrease and the corresponding decrease in selling expenses as a percentage of sales were primarily due to cost containment initiatives and the impact of foreign currency translation.

Corporate administrative expenses for the first nine months of 2015 were $36.3 million, an increase of $0.1 million or 0.3%, compared with $36.2 million for the first nine months of 2014. As a percentage of net sales, corporate administrative expenses were 1.2% for both the first nine months of 2015 and 2014.

Consolidated operating income was $698.9 million or 23.4% of net sales for the first nine months of 2015, an increase of $27.4 million or 4.1%, compared with $671.5 million or 22.4% of net sales for the first nine months of 2014.

 

20


Table of Contents

Results of Operations (continued)

 

Interest expense was $69.0 million for the first nine months of 2015, an increase of $11.6 million or 20.2%, compared with $57.4 million for the first nine months of 2014. The increase was due to the impact of private placement senior notes funded in the second and third quarters of 2015 and the third quarter of 2014.

Other expenses, net were $6.3 million for the first nine months of 2015, a decrease of $10.5 million, compared with $16.8 million for the first nine months of 2014. The first nine months of 2014 included a $5.5 million reversal of an insurance policy receivable related to a specific uncertain tax position liability of an acquired entity discussed further below. The decrease was also driven by lower acquisition-related expenses.

The effective tax rate for the first nine months of 2015 was 27.2%, compared with 27.6% for the first nine months of 2014. The effective tax rates for the first nine months of 2015 and 2014 reflect the impact of foreign earnings, which are taxed at lower rates. The first nine months of 2015 effective tax rate reflects the first quarter of 2015 release of uncertain tax position liabilities related to the conclusion of an advance thin capitalization agreement in the European Union, the second quarter of 2015 effective settlement of the U.S. research and development tax credit from a recently completed Internal Revenue Service examination for 2010 and 2011, and the third quarter of 2015 $7.5 million of tax benefits related to the closure of an international subsidiary. The first nine months of 2014 effective tax rate reflects a release of $12.9 million of uncertain tax position liabilities related to an acquired entity due to the final closure of a tax year.

Net income for the first nine months of 2015 was $454.0 million, an increase of $21.5 million or 5.0%, compared with $432.5 million for the first nine months of 2014. The first quarter of 2015 realignment costs reduced the first nine months of 2015 net income by $10.8 million. The third quarter of 2014 Zygo integration costs reduced the first nine months of 2014 net income by $10.7 million. Diluted earnings per share for the first nine months of 2015 were $1.87, an increase of $0.12 or 6.9%, compared with $1.75 per diluted share for the first nine months of 2014.

Segment Results

EIG’s net sales totaled $1,788.8 million for the first nine months of 2015, an increase of $11.5 million or 0.6%, compared with $1,777.3 million for the first nine months of 2014. The 2015 acquisition of Surface Vision and the 2014 acquisitions of Amptek and Zygo accounted for 4% of the net sales increase, partially offset by an unfavorable 4% effect of foreign currency translation. Internal sales growth was flat period over period.

EIG’s operating income was $477.7 million for the first nine months of 2015, an increase of $27.6 million or 6.1%, compared with $450.1 million for the first nine months of 2014. EIG’s increase in operating income was primarily due to the Group’s Operational Excellence initiatives, partially offset by $9.3 million of first quarter of 2015 realignment costs. EIG’s first nine months of 2014 operating income included $13.7 million of Zygo integration costs. EIG’s operating margins were 26.7% of net sales for the first nine months of 2015, compared with 25.3% of net sales for the first nine months of 2014. EIG’s increase in operating margins resulted primarily from the benefits of the Group’s Operational Excellence initiatives, partially offset by the approximately 50 basis points negative impact from the realignment costs noted above. EIG’s first nine months of 2014 operating margins were negatively impacted by approximately 80 basis points due to the Zygo integration costs noted above.

EMG’s net sales totaled $1,197.5 million for the first nine months of 2015, a decrease of $23.1 million or 1.9%, compared with $1,220.6 million for the first nine months of 2014. The net sales decrease was due to an unfavorable 5% effect of foreign currency translation, partially offset by a 3% increase from the 2015 acquisition of Global Tubes. Internal sales growth was flat period over period.

EMG’s operating income was $257.9 million for the first nine months of 2015, a decrease of $0.1 million or flat on a percentage basis, compared with $258.0 million for the first nine months of 2014. EMG’s decrease in operating income was primarily due to the lower sales mentioned above and included $6.5 million of first quarter of 2015 realignment costs, partially offset by the benefits of the Group’s Operational Excellence initiatives. EMG’s operating margins were 21.5% of net sales for the first nine months of 2015, compared with 21.1% of net sales for the first nine months of 2014. For the first nine months of 2015, the benefits of the Group’s Operational Excellence initiatives offset the approximately 60 basis points negative impact from the realignment costs described above.

 

21


Table of Contents

Financial Condition

Liquidity and Capital Resources

Cash provided by operating activities totaled $473.1 million for the first nine months of 2015, a decrease of $39.6 million or 7.7%, compared with $512.7 million for the first nine months of 2014. The decrease in cash provided by operating activities was primarily due to the $49.8 million increase in defined benefit pension plan contributions, driven by a $50.0 million contribution to the Company’s U.S. defined benefit pension plans in the first quarter of 2015. Free cash flow (cash flow provided by operating activities less capital expenditures) was $427.8 million for the first nine months of 2015, compared with $465.4 million for the first nine months of 2014. EBITDA (earnings before interest, income taxes, depreciation and amortization) was $802.1 million for the first nine months of 2015, compared with $757.0 million for the first nine months of 2014. Free cash flow and EBITDA are presented because the Company is aware that they are measures used by third parties in evaluating the Company.

Cash used for investing activities totaled $401.9 million for the first nine months of 2015, compared with $617.6 million for the first nine months of 2014. For the first nine months of 2015, the Company paid $356.5 million, net of cash acquired, to acquire the Surface Vision in July 2015 and Global Tubes in May 2015. For the first nine months of 2014, the Company paid $573.6 million, net of cash acquired, to acquire Teseq Group in January 2014, VTI Instruments in February 2014, Luphos GmbH in May 2014, Zygo Corporation in June 2014 and Amptek, Inc. in August 2014. Additions to property, plant and equipment totaled $45.3 million for the first nine months of 2015, compared with $47.3 million for the first nine months of 2014.

Cash used for financing activities totaled $101.1 million for the first nine months of 2015, compared with $193.9 million of cash provided by financing activities for the first nine months of 2014. For the first nine months of 2015, the Company repurchased approximately 5,576,000 shares of its common stock for $306.5 million, compared with $1.9 million used for repurchases of approximately 36,000 shares for the first nine months of 2014. On April 1, 2015, the Company’s Board of Directors approved an increase of $350 million in the authorization for repurchase of the Company’s common stock. At September 30, 2015, $90.6 million was available under the Company’s Board of Directors authorization for future share repurchases.

On November 4, 2015, the Company’s Board of Directors approved an increase of $350 million in the authorization for repurchase of the Company’s common stock.

Short-term borrowings increased $160.2 million for the first nine months of 2015, compared with a decrease of $262.9 million for the first nine months of 2014. Long-term borrowings increased $53.1 million for the first nine months of 2015, compared to an increase of $499.5 million for the first nine months of 2014.

In August 2015, the Company obtained the third funding of $150 million, consisting of $100 million in aggregate principal amount of 3.96% senior notes due August 2025 and $50 million in aggregate principal amount of 4.45% senior notes due August 2035 under the third quarter of 2014 private placement agreement. In June 2015, the Company obtained the second funding of $50 million in aggregate principal amount of 3.91% senior notes due June 2025 under the third quarter of 2014 private placement agreement. The first funding occurred in September 2014 for $500 million, consisting of $300 million in aggregate principal amount of 3.73% senior notes due September 2024, $100 million in aggregate principal amount of 3.83% senior notes due September 2026 and $100 million in aggregate principal amount of 3.98% senior notes due September 2029. The senior notes carry a weighted average interest rate of 3.88%. The senior notes are subject to certain customary covenants, including financial covenants that, among other things, require the Company to maintain certain debt to EBITDA (earnings before interest, income taxes, depreciation and amortization) and interest coverage ratios. The proceeds from the third funding of the senior notes were used to pay down senior notes that matured in the third quarter of 2015 described further below. The proceeds from the second funding of the senior notes were used to pay down domestic borrowings under the Company’s revolving credit facility.

In the third quarter of 2015, the Company paid in full, at maturity, $90 million in aggregate principal amount of 6.59% private placement senior notes and 50 million Euro ($56.4 million) 3.94% senior note.

 

22


Table of Contents

Financial Condition (continued)

 

At September 30, 2015, total debt outstanding was $1,917.1 million, compared with $1,714.0 million at December 31, 2014. In the fourth quarter of 2015, $35 million of debt will mature and become payable. The debt-to-capital ratio was 36.6% at September 30, 2015, compared with 34.6% at December 31, 2014. The net debt-to-capital ratio (total debt less cash and cash equivalents divided by the sum of net debt and stockholders’ equity) was 32.4% at September 30, 2015, compared with 29.2% at December 31, 2014. The net debt-to-capital ratio is presented because the Company is aware that this measure is used by third parties in evaluating the Company.

As a result of all of the Company’s cash flow activities for the first nine months of 2015, cash and cash equivalents at September 30, 2015 totaled $328.0 million, compared with $377.6 million at December 31, 2014. At September 30, 2015, the Company had $298.7 million in cash outside the United States, compared with $352.8 million at December 31, 2014. The Company utilizes this cash to fund its international operations, as well as to acquire international businesses. In May 2015, the Company acquired Global Tubes for $198.8 million utilizing cash outside the United States. The Company is in compliance with all covenants, including financial covenants, for all of its debt agreements. The Company believes it has sufficient cash-generating capabilities from domestic and unrestricted foreign sources, available credit facilities and access to long-term capital funds to enable it to meet its operating needs and contractual obligations in the foreseeable future.

Contractual Obligations

As mentioned above, in August and June 2015, the Company obtained the third and second fundings, respectively, under the third quarter of 2014 private placement agreement for $700 million in senior notes (the first funding occurred in September 2014). Also mentioned above, in the third quarter of 2015, the Company paid in full, at maturity, $90 million in aggregate principal amount of 6.59% private placement senior notes and 50 million Euro ($56.4 million) 3.94% senior note. At September 30, 2015, the Company had $257.3 million of borrowings outstanding under the revolving credit facility. As a result of the net increase in borrowings described above, the Company’s obligation for long-term debt, revolving credit loans and interest on long-term fixed-rate debt will increase compared with the obligations noted at December 31, 2014. See Note 11 to the Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q for further details.

As mentioned above, the Company recorded first quarter of 2015 pre-tax realignment costs totaling $15.9 million. At September 30, 2015, the Company had $7.6 million reported as Accrued liabilities in the Company’s consolidated balance sheet related to this restructuring, which increases the employee severance obligation noted at December 31, 2014. See Note 16 to the Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q for further details.

There have been no other material changes to the contractual obligations table presented in our Annual Report on Form 10-K for the year ended December 31, 2014.

Forward-Looking Information

Information contained in this discussion, other than historical information, is considered “forward-looking statements” and is subject to various factors and uncertainties that may cause actual results to differ significantly from expectations. These factors and uncertainties include general economic conditions affecting the industries the Company serves; changes in the competitive environment or the effects of competition in the Company’s markets; risks associated with international sales and operations; the Company’s ability to consummate and successfully integrate future acquisitions; the Company’s ability to successfully develop new products, open new facilities or transfer product lines; the price and availability of raw materials; compliance with government regulations, including environmental regulations; and the ability to maintain adequate liquidity and financing sources. A detailed discussion of these and other factors that may affect the Company’s future results is contained in AMETEK’s filings with the U.S. Securities and Exchange Commission, including its most recent reports on Form 10-K, 10-Q and 8-K. AMETEK disclaims any intention or obligation to update or revise any forward-looking statements, unless required by the securities laws to do so.

 

23


Table of Contents

Item 4. Controls and Procedures

The Company maintains a system of disclosure controls and procedures that is designed to provide reasonable assurance that information, which is required to be disclosed, is accumulated and communicated to management in a timely manner. Under the supervision and with the participation of our management, including the Company’s principal executive officer and principal financial officer, we have evaluated the effectiveness of our system of disclosure controls and procedures as required by Exchange Act Rule 13a-15(b) as of September 30, 2015. Based on that evaluation, the Company’s principal executive officer and principal financial officer concluded that the Company’s disclosure controls and procedures are effective at the reasonable assurance level.

Such evaluation did not identify any change in the Company’s internal control over financial reporting during the quarter ended September 30, 2015 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

24


Table of Contents

PART II. OTHER INFORMATION

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

(c) Purchase of equity securities by the issuer and affiliated purchasers.

The following table reflects purchases of AMETEK, Inc. common stock by the Company during the three months ended September 30, 2015:

 

Period

  Total Number
of Shares Purchased (1)(2)
    Average Price
Paid per Share
    Total Number of
Shares Purchased as

Part of Publicly
Announced Plan (2)
    Approximate
Dollar Value of
Shares that
May Yet Be
Purchased Under
the Plan
 

July 1, 2015 to July 31, 2015

    1,507      $ 52.45        1,507      $ 339,828,263   

August 1, 2015 to August 31, 2015

    3,754,045        55.55        3,754,045        131,273,561   

September 1, 2015 to September 30, 2015

    745,955        54.51        745,955        90,609,705   
 

 

 

     

 

 

   

Total

    4,501,507        55.38        4,501,507     
 

 

 

   

 

 

   

 

 

   

 

(1) Includes 1,507 shares surrendered to the Company to satisfy tax withholding obligations in connection with employees’ share-based compensation awards.
(2) Consists of the number of shares purchased pursuant to the Company’s Board of Directors $350 million authorization for the repurchase of its common stock announced in April 2015. Such purchases may be affected from time to time in the open market or in private transactions, subject to market conditions and at management’s discretion.

 

25


Table of Contents

Item 6. Exhibits

 

Exhibit

Number

  

Description

31.1    Certification of Chief Executive Officer, Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2    Certification of Chief Financial Officer, Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1    Certification of Chief Executive Officer, Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2    Certification of Chief Financial Officer, Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS    XBRL Instance Document.
101.SCH    XBRL Taxonomy Extension Schema Document.
101.CAL    XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF    XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB    XBRL Taxonomy Extension Label Linkbase Document.
101.PRE    XBRL Taxonomy Extension Presentation Linkbase Document.

 

26


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

AMETEK, Inc.
(Registrant)
By:   /s/ William J. Burke
  William J. Burke
  Senior Vice President - Comptroller & Treasurer
  (Principal Accounting Officer)

November 5, 2015

 

27